{"title":"(为什么使用固定剂量培哚普利、比索洛尔联合治疗冠心病高渗症?)","authors":"O. Petrák","doi":"10.33678/cor.2023.004","DOIUrl":null,"url":null,"abstract":"of these drugs effectively reduces blood pressure and heart rate, which improves the cardiovascular prognosis of selected patients. The article is devoted to the indications of these drugs in patients both in the treatment of uncomplicated hypertension and in secondary prevention in patients with ischemic heart disease. The emphasis is placed especially on the position of beta-blockers. Klíčová slova:","PeriodicalId":10787,"journal":{"name":"Cor et vasa","volume":" ","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"(Why to use fixed dose perindopril, bisoprolol combination in hypertonics with CHD?)\",\"authors\":\"O. Petrák\",\"doi\":\"10.33678/cor.2023.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"of these drugs effectively reduces blood pressure and heart rate, which improves the cardiovascular prognosis of selected patients. The article is devoted to the indications of these drugs in patients both in the treatment of uncomplicated hypertension and in secondary prevention in patients with ischemic heart disease. The emphasis is placed especially on the position of beta-blockers. Klíčová slova:\",\"PeriodicalId\":10787,\"journal\":{\"name\":\"Cor et vasa\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2023-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cor et vasa\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33678/cor.2023.004\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cor et vasa","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33678/cor.2023.004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
(Why to use fixed dose perindopril, bisoprolol combination in hypertonics with CHD?)
of these drugs effectively reduces blood pressure and heart rate, which improves the cardiovascular prognosis of selected patients. The article is devoted to the indications of these drugs in patients both in the treatment of uncomplicated hypertension and in secondary prevention in patients with ischemic heart disease. The emphasis is placed especially on the position of beta-blockers. Klíčová slova:
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
